Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 20, 2008
Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitorsW K Hoots, L S Ebbesen, B A Konkle, et al.
Actas Dermo-Sifiliograficas|July 14, 2020
Dermatologists' Role in the Early Diagnosis of Psoriatic Arthritis: Expert RecommendationsI Belinchón, L Salgado-Boquete, A López-Ferrer, et al.
Actas Dermo-Sifiliograficas|May 14, 2020
Linguistic and Cultural Adaptation to Spanish of the Screening Tool Psoriatic Arthritis UnclutteRed Screening Evaluation (PURE4)I Belinchón, R Queiro, L Salgado-Boquete, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 15, 2018
Initial results of ixekizumab efficacy and safety in real-world plaque psoriasis patients: a multicentre retrospective studyG Deza, J Notario, A Lopez-Ferrer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 18, 2014
Use of biological treatments in patients with hidradenitis suppurativaG Martin-Ezquerra, E Masferrer, M Masferrer-Niubò, et al.
Plos One|March 2, 2026
Validation of performance of Spanish version of PURE-4 questionnaire for early identification of psoriatic arthritis after 1 year of follow-up in patients with psoriasisR Queiro-Silva, A López-Ferrer, M Ferran I Farrés, et al.
Actas Dermo-Sifiliograficas|March 13, 2010
[Adverse reactions during biological therapy for psoriasis: results of a survey of the Spanish Psoriasis Group]M Sánchez-Regaña, E Dilmé, Ll Puig, et al.
The Journal of Dermatological Treatment|September 9, 2020
Unmet needs in patients with moderate-to-severe plaque psoriasis treated with methotrexate in real world practice: FirST studyRaquel Rivera, E Vilarrasa, M Ribera, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 10, 2020
Real-world effectiveness and safety of apremilast in psoriasis at 52 weeks: a retrospective, observational, multicentre study by the Spanish Psoriasis GroupE Del Alcázar, J A Suárez-Pérez, S Armesto, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 28, 2023
Pharmacogenetic biomarkers for secukinumab response in psoriasis patients in real-life clinical practiceE Muñoz-Aceituno, B Butrón-Bris, M C Ovejero-Benito, et al.
Pageof 3